No paralogue variants have been mapped to residue 784 for SCN5A.
SCN5A | LVFTGIFTAEMTFKIIALDPYYYFQQGWNI>F<DSIIVILSLMELGLSRMS-----NLSVLRS | 809 |
SCN1A | LVFTGIFTAEMFLKIIAMDPYYYFQEGWNI>F<DGFIVTLSLVELGLANVE-----GLSVLRS | 860 |
SCN2A | LVFTGIFTAEMFLKIIAMDPYYYFQEGWNI>F<DGFIVSLSLMELGLANVE-----GLSVLRS | 851 |
SCN3A | LVFTGIFTAEMVLKIIAMDPYYYFQEGWNI>F<DGIIVSLSLMELGLSNVE-----GLSVLRS | 852 |
SCN4A | LVFTGIFTAEMVLKLIAMDPYEYFQQGWNI>F<DSIIVTLSLVELGLANVQ-----GLSVLRS | 670 |
SCN7A | LVFIGIFTAEMIFKIIAMHPYGYFQVGWNI>F<DSMIVFHGLIELCLANVA-----GMALLRL | 597 |
SCN8A | LVFTGIFTAEMFLKLIAMDPYYYFQEGWNI>F<DGFIVSLSLMELSLADVE-----GLSVLRS | 845 |
SCN9A | LVFTGIFAAEMVLKLIAMDPYEYFQVGWNI>F<DSLIVTLSLVELFLADVE-----GLSVLRS | 825 |
SCN10A | IVFTIFFTAEMVFKIIAFDPYYYFQKKWNI>F<DCIIVTVSLLELGVAKKG-----SLSVLRS | 757 |
SCN11A | LVFTSIFIAEMCLKIIALDPYHYFRRGWNI>F<DSIVALLSFADVMNCVLQKR---SWPFLRS | 671 |
CACNA1A | FIFLGLFMSEMFIKMYGLGTRPYFHSSFNC>F<DCGVIIGSIFEVIWAVIKPGTSFGISVLRA | 584 |
CACNA1B | FVFLGLFLTEMSLKMYGLGPRSYFRSSFNC>F<DFGVIVGSVFEVVWAAIKPGSSFGISVLRA | 580 |
CACNA1C | KALLALFTAEMLLKMYSLGLQAYFVSLFNR>F<DCFVVCGGILETILVETKIMSPLGISVLRC | 621 |
CACNA1D | KVLLALFTCEMLVKMYSLGLQAYFVSLFNR>F<DCFVVCGGITETILVELEIMSPLGISVFRC | 640 |
CACNA1E | FLFLGLFLLEMSLKMYGMGPRLYFHSSFNC>F<DFGVTVGSIFEVVWAIFRPGTSFGISVLRA | 573 |
CACNA1F | KVLLCLFTVEMLLKLYGLGPSAYVSSFFNR>F<DCFVVCGGILETTLVEVGAMQPLGISVLRC | 626 |
CACNA1G | IVFTSLFALEMLLKLLVYGPFGYIKNPYNI>F<DGVIVVISVWEIVGQQGG-----GLSVLRT | 835 |
CACNA1H | IVFTSMFALEMLLKLLACGPLGYIRNPYNI>F<DGIIVVISVWEIVGQADG-----GLSVLRT | 885 |
CACNA1I | VVFTSMFALEMILKLAAFGLFDYLRNPYNI>F<DSIIVIISIWEIVGQADG-----GLSVLRT | 732 |
CACNA1S | RVLLSLFTTEMLMKMYGLGLRQYFMSIFNR>F<DCFVVCSGILEILLVESGAMTPLGISVLRC | 529 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.F784L | c.2350T>C | Putative Benign | SIFT: Polyphen: |